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Abstract 
 
Background 
Pertussis (whooping cough) is a highly infective cause of cough that causes significant 
morbidity and mortality. Existing case definitions include paroxysmal cough, whooping and 
post-tussive vomiting but diagnosis can be difficult. We determined the diagnostic accuracy of 
clinical characteristics of pertussis-associated cough. 
  
Methods 
We systematically searched CINAHL, Embase, Medline and SCI-EXPANDED/CPCI-S up to 
June 2016. Eligible studies compared clinical characteristics in those positive and negative for 
Bordetella pertussis infection, confirmed by laboratory investigations. Two authors 
independently completed screening, data extraction and quality and bias assessments. For 
each characteristic RevMan was used to produce descriptive forest plots. We used the 
bivariate meta-analysis method to generate pooled estimates of sensitivity and specificity.  
 
Results 
Of 1969 identified papers, 53 were included. Forty-one clinical characteristics were assessed 
for diagnostic accuracy. In adult patients, paroxysmal cough and absence of fever had a high 
sensitivity (93.2%, CI 83.2-97.4 and 81.8%, CI 72.2-88.7 respectively) and low specificity 
(20.6%, CI 14.7-28.1 and 18.8%, CI 8.1-37.9 respectively), whereas post-tussive vomiting 
and whooping had low sensitivity (32.5%, CI 24.5-41.6 and 29.8%, CI 8.0-45.2 respectively) 
and high specificity (77.7%, CI 73.1-81.7 and 79.5%, CI 69.4-86.9 respectively). Post-tussive 
vomiting in children is moderately sensitive (60.0%, CI 40.3-77.0) and specific 66.0%, CI 
52.5-77.3). 
 
Conclusions 
In adult patients the presence of whooping or post-tussive vomiting should rule in a possible 
diagnosis of pertussis, whereas the lack of a paroxysmal cough or the presence of fever 
should rule it out. In children, post-tussive vomiting is much less helpful as a clinical 
diagnostic test. 
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Introduction 
Pertussis (whooping cough), caused by Bordetella pertussis infection, is a prevalent cause of 
acute cough that can often become persistent in both children and adults presenting to 
primary care and other health care settings.1,2 Pertussis remains an important cause of child 
mortality, with an estimated 195,000 deaths reported globally in 2008.3 In older age groups 
pertussis causes significant morbidity and generates substantial costs and work absence.4 
Neither natural infection nor immunisation result in life-long immunity.5  
 
The symptom triad of paroxysmal cough, whooping and post-tussive vomiting are classically 
considered essential clinical characteristics, and the Center for Disease Control (CDC) and 
World Health Organization (WHO) clinical case definitions reflect this.6,7 However, in clinical 
practice pertussis-associated cough can occur anywhere along a clinical severity spectrum 
from minor cough to repeated severe paroxysms.8,9 Previous immunisation or infection can 
attenuate the symptoms, especially cough, that occur with a subsequent B. pertussis 
infection.10 The disease frequently also presents atypically in young infants.11,12  
 
Laboratory confirmation of B. pertussis infection can be performed using culture (100% 
specific), polymerase chain reaction (PCR) (88-100% specific), or serology (72-100% 
specific).13,14 However, a practising clinician who needs to make an urgent patient 
management decision frequently has to do this without laboratory data. Identifying pertussis 
as the cause of a clinical presentation of cough illness is important because of the high 
infectivity of B. pertussis,8 its significant morbidity and the potential for complications and 
death, particularly in young infants.15 Offering a secure clinical diagnosis also helps prevent 
unnecessary investigations, inappropriate antibiotics and offers patients a more accurate 
cough prognosis. Early recognition and treatment may also prevent spread of the disease. 
 
Although the diagnostic accuracy for pertussis of different symptoms and signs has been 
tested in multiple clinical studies, they have not previously been combined in a 
comprehensive systematic review. A better understanding of the clinical characteristics of 
pertussis-associated cough, and other clinical features could help clinicians differentiate 
pertussis cough from other causes of cough. 
 
We therefore aimed to conduct a systematic review and meta-analysis to determine the 
diagnostic accuracy of clinical characteristics of pertussis-associated cough. 
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Materials and methods 
 
Study selection and data extraction 
A diagnostic test accuracy protocol was developed using the relevant Cochrane handbook16 
but not formally registered (available on request). We considered as eligible studies which 
included patients of any age attending any health care setting, including pertussis outbreaks, 
with any clinical characteristic (index test) which might be associated with pertussis, 
compared to laboratory confirmation of B. pertussis (reference standard). We included all 
studies with sufficient published or unpublished data to construct 2x2 tables for each clinical 
characteristic(s). Studies were excluded if pertussis diagnosis was not confirmed with 
recognised laboratory methods (culture, PCR or serology) or there was no suitable 
comparison group. Studies looking at B. parapertussis only were also excluded. By design 
our inclusion criteria were broad in order to capture the full spectrum of pertussis 
presentation. 
 
We systematically searched databases CINAHL(EBSCOHost, 1982-present], Embase 
(OvidSP, 1974-2016 June 02), Medline & Medline In-Process (OvidSP, 1946-present) and 
SCI-EXPANDED/CPCI-S(Web of Science Core Collection, 1945-present) from inception to 
November 2014, and this was then updated in June 2016. The search strategy combined 
MeSH headings with free text search terms for whooping cough and clinical symptoms. 
English language restrictions were applied. Results were supplemented by review of 
reference lists of included articles and relevant review articles. e-Appendix 1 gives the full 
search strategy used for CINAHL as an example. 
 
Titles and abstracts were screened to exclude any obviously irrelevant articles. Full texts of 
potentially relevant articles were then assessed for eligibility. All steps were completed in 
tandem by two authors (HFA and AM), with any discrepancies discussed and, if necessary, 
resolved by adjudication with a third author (AH). We contacted authors of studies to request 
additional data relevant to this review where it was apparent that it was likely to have been 
collected but not published. Authors were contacted by email, with a reminder sent at 2 
weeks and 4 weeks if no response. We developed and piloted a standardised data extraction 
form, which was revised until it captured all relevant information. This data extraction form 
was sent to facilitate return of data in a useable format. 
 
Data extraction and risk of bias assessment were subsequently carried out in duplicate and 
independently by HFA and AM. Risk of bias was assessed using the QUADAS-2 tool in the 
domains of patient selection, index tests, reference standard and flow and timing.17 
Completed data extraction forms were compared and any discrepancies checked and 
resolved. We extracted information on study characteristics, design, details of the reference 
test used for pertussis detection, the characteristics of included patients and information on 
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missing data. For each clinical characteristic described, data for a 2x2 table were extracted or 
calculated from the data presented. Data were entered into a Microsoft Excel spreadsheet by 
one author (AM) and checked by a second (HFA). Terms used to describe clinical 
characteristics varied slightly across studies. Similar characteristics were grouped together 
using clinical judgement by one author (HFA) and checked by a second (AM). 
 
Statistical analysis 
Statistical analysis was completed by BS. Binary diagnostic accuracy data were extracted 
from all included studies as 2x2 tables. For each clinical characteristic, RevMan was used to 
produce descriptive forest plots to explore the between-study variability in sensitivity and 
specificity across the included studies. ROC plots were produced, sub-grouped by age of 
included participants (children, adults or both). The size of each study point is scaled to be 
proportional to the inverse standard error of the study sensitivity and specificity. 
 
Where sufficient data were available (minimum of four studies), we used the bivariate meta-
analysis method to generate pooled estimates of sensitivity and specificity, along with 95% 
confidence and prediction regions. Results were only pooled within each age-range of patient, 
categorised as either children or adults. Studies with both adults and children were not 
included as the presentation of the disease in the age groups are not the same.11 Due to high 
heterogeneity, we excluded from meta-analyses studies at high risk of bias on any of the four 
QUADAS-2 domains, which was a pre-specified sensitivity analysis. In cases where notable 
heterogeneity remained, meta-analysis was deemed inappropriate. 
 
We planned additional sub-group analyses to explore other possible causes of heterogeneity 
(co-morbidity, immunisation status, setting) however there were insufficient study data 
available. We had also planned to adjust for possible sources of heterogeneity by adding 
them as covariates to the bivariate model. However, we could not do the meta-regression as 
we did not have enough studies to warrant the addition of variables. Assessment of reporting 
bias was not included in this review, as funnel plots have been shown to be misleading for 
reviews of diagnostic test accuracy.18,19 
 
 
Results 
Figure 1 shows the flowchart of study selection. We identified 1969 unique papers, of which 
422 had a full text review. Forty-seven studies met inclusion criteria for this review and 
contained sufficient data in the published article for complete data extraction. Fourteen further 
papers were identified with potential unpublished data. The authors of these papers were 
contacted, of which 6 provided the necessary information. Overall 53 papers were included in 
descriptive analysis and meta-analysis (where possible). 
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Table 120-72 summarises characteristics of included studies. The 53 studies included 23796 
participants, of whom 4149 (17.4%) had a laboratory diagnosis of pertussis. The proportion of 
study cohorts with laboratory-confirmed pertussis ranged from 0.3-72.5% (mean 24.7%).  
Thirty-seven studies had a prospective design, 12 were retrospective and 4 were case-
control. Inclusion criteria and reference standard varied widely across studies. Ten studies 
took place during a pertussis outbreak but the majority of papers did not report this. Those 
with at least one vaccination dose (recorded in 36 studies) ranged from 0 to 100% (mean 
54.3%).  
 
Risk of bias assessment with QUADAS-2 is summarised in Figure 2. Nineteen studies had 
low risk of bias/low applicability concerns throughout all 7 domains. Twenty-two studies were 
assessed at high risk of bias in at least one of the 4 domains. 
    
Across the 53 included studies, 41 index tests were assessed for diagnostic accuracy, 
including 9 cough characteristics as well as other clinical and demographic features 
(Table 2). Forest plots were generated for each index test, which demonstrate the 
heterogeneity between studies. These are presented in e-Appendix 2. 
 
After pre-specified meta-analysis exclusions (see methods), pooled estimates of sensitivity 
and specificity were generated (Table 3). Meta-analysis is not presented for immunisation due 
to wide heterogeneity in immunisations at different ages and different countries. Figure 3 
shows Receiver Operating Characteristic (ROC) plots of the meta-analyses. 
Discussion 
Summary of evidence 
Our meta-analysis demonstrates four key characteristics that are important in ruling in or out 
a clinical diagnosis of pertussis: paroxysmal cough, post-tussive vomiting, inspiratory whoop 
and absence of fever.  
 
We found paroxysmal cough and absence of fever in adults have high sensitivity and low 
specificity. The clinical implication is that if an adult patient does not have paroxysmal cough, 
or does have a fever they are very unlikely to have pertussis - good ‘rule out’ tests. 
 
Both post-tussive vomiting and whooping in adults have a low sensitivity and high specificity. 
The clinical implication is that if an adult patient has post-tussive vomiting or whooping, it 
raises suspicion of pertussis as a differential diagnosis – making both these good ‘rule in’ 
tests. Post-tussive vomiting in children, however, is only moderately sensitive and specific. 
This makes it much less helpful as a clinical diagnostic test than in adults. 
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The forest plots and summary ROC plots demonstrate large statistical heterogeneity within 
the data synthesised across the other index tests and interpretation of these data should be 
approached with caution. Index tests with a trend suggesting better sensitivity for diagnosis of 
pertussis include cough worse at night (sensitive but not specific in adults) and apnoea and 
cyanosis (moderately sensitive and specific in children). Lymphocytosis may be a relatively 
sensitive marker for pertussis infection in children, but only 3 studies assessed this and all 
used different thresholds.58,62,72 This finding would fit with what is already known about the 
effect of pertussis toxin in increasing the number of circulating white blood cells in infants with 
whooping cough.73 
 
Comparison with existing literature 
There are a number of different clinical case definitions currently in use globally including 
those created by the United States Centers for Disease Control,6 Public Health England 
(PHE) 74 and World Health Organization.7 In common across all three sets of criteria is the 
cough lasting at least 14 days - an inclusion criterion of some of studies included in this 
review.27,33,38,41-43,51,56,59,69,71 Unfortunately, cough or symptom duration was used as an index 
test by some included studies, but often without indicating whether this was at presentation or 
overall. It could not be evaluated diagnostically.  The presence of whooping or post-tussive 
vomiting is also common to the CDC, PHE and WHO clinical criteria, whilst paroxysms of 
coughing is included by CDC and WHO. This classical triad of symptoms are the index tests 
that our meta-analysis has shown should raise clinical suspicion of pertussis.   
 
A person suspected by a physician of having pertussis is included in its own right as a 
criterion in the PHE and WHO criteria. This formed part of the inclusion criteria of a number of 
studies in this review,29,35,54 but was only used as an index test in 3 studies,35,39,44 which may 
explain the wide-ranging prevalence found across studies. 
 
Apnoea and cyanosis are mentioned in relation to infants aged < 1 year in the CDC criteria, 
and are shown in our Forest plots (e-Appendix 2) to be moderately sensitive and specific in 
children. 
 
There is one previous diagnostic accuracy systematic review of these classically described 
symptoms of pertussis (paroxysmal cough, post-tussive vomiting, and inspiratory whoop).75 
This was completed in 2010 and included three studies with patients over 5 years of age in a 
non-outbreak setting.38,49,63 Like our meta-analysis, it showed that paroxysmal cough has low 
specificity in older patients, and that the presence of whooping and post-tussive vomiting 
modestly increased the likelihood of pertussis. However, given all three symptoms had only 
relatively modest positive likelihood ratios between 1.1-1.9 the authors concluded that 
presence of these symptoms were of limited value in differentiating a pertussis diagnosis from 
other respiratory illnesses, and that overall clinical judgement was important. Our systematic 
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review extends this smaller study, by having broader inclusion criteria and considering other 
clinical symptoms as index tests. 
 
Strengths and limitations 
The broad eligibility criteria for this systematic review meant that we collected data from over 
fifty studies and were therefore able to include information on a large numbers of patients, 
making this the largest systematic review on this topic to date. However, this has also meant 
that there is a wide variation in study characteristics, which is likely to have contributed to the 
heterogeneity of our results. 
 
A number of included studies were classed as high risk of bias for patient selection and were 
therefore not included in meta-analysis.  Some listed features of pertussis as part of their 
inclusion criteria26,30,31,53,58,60,63,70 whilst others specifically recruited patients with suspected 
pertussis29,35,54 or included all patients who had had a laboratory test for pertussis.32,37,44,64,68,72  
 
Misclassification bias is likely to have been influential at both the study and review level as 
very few papers described the clinical features being assessed. There was also a lack of 
clarity in some papers as to whether a feature described was from the patient history or 
examination (e.g. fever). This is likely to have caused inconsistency in study data collection 
as well as synthesis of data in the systematic review – particularly when grouping similar 
characteristics together. 
 
Use of single or a combination of reference standards also varied across studies. However, 
methods for all reference standards were compared to the CDC guidelines,13 and lack of 
transparency or deviation from these was reflected in the corresponding domain in the risk of 
bias assessment.  In addition, many papers lacked details in the reporting of design setting 
(including whether or not there was an outbreak), and patient demographic (age, sex and 
immunisation status). It was therefore not possible to assess pre-test probability of pertussis 
is these studies. 
 
For the purposes of systematic review we separated studies looking at adults and children, 
and excluded those that included patients of all ages. This is because it has been recognised 
that pertussis in adults and children does not present in the same way. However, an 
additional limitation is that our ‘children’ category includes studies with both older children and 
young infants who may also have very different presentations of pertussis. 
 
Conclusions 
There is substantial statistical heterogeneity between all included studies, which reflects 
heterogeneity in study designs used.  As a result, meta-analysis was only possible of a limited 
number of clinical characteristics – predominantly in adult patients.  The results of the meta-
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analysis showed that recognising the classical triad of symptoms in adults remains helpful for 
clinicians.  In adult patients the presence of whooping or post-tussive vomiting should rule in 
a possible diagnosis of pertussis, whereas the lack of a paroxysmal cough or the presence of 
fever should rule it out. In children, however, presence of post-tussive vomiting is much less 
helpful as a clinical diagnostic test and pooled estimates of sensitivity and specificity for other 
characteristics could not be calculated. 
 
Further high quality research is needed to better understand which clinical characteristics can 
differentiate pertussis associated cough from other causes of cough. Particular consideration 
should be taken as to the entry criteria/patient population most likely to produce data that can 
be clinically useful. In addition, clear descriptions of clinical characteristics under testing are 
important to ensure consistent interpretation and reporting. Future research is likely to involve 
large prospective studies in primary care, as well as individual patient data analysis to assess 
the diagnostic utility of different symptoms in combination with the possibility of creating a 
scoring system to identify patients for definitive testing. 
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Figure legends 
 
Figure 1.  
Flow of the citations reviewed in the course of this systematic review. 
 
Figure 2. 
Risk of bias and applicability concerns summary: review authors' judgements about each 
domain for each included study. 
 
Figure 3. 
Summary Receiver Operating Characteristic plots depicting meta-analysis of various clinical 
characteristics in adults and children. The summary point represents the summary sensitivity 
and specificity, the 95% confidence region represents the 95% confidence intervals of the 
summary sensitivity and specificity and the 95% prediction region represents the 95% 
confidence interval of sensitivity and specificity of each individual study included in the 
analysis. Individual study estimates are also plotted indicating individual sensitivity and 
specificity with the size of the marker scaled according to the total number in each study.  
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Table 1. Characteristics of 53 included studies 
Overview of all included studies. For more detailed characteristics, see e-Table 1 
 
 
 Study Country (ies) Setting Inclusion criteria Study type 
Laboratory test 
Total 
number of 
participants 
Age 
category 
Number (%) 
laboratory 
confirmed 
pertussis Culture Serology PCR DFA 
Abu Raya et al5 Israel Secondary care 
<= 4 days of clinically diagnosed acute 
bronchiolitis Case control    俸   120 Children 23 (19.17) 
Bellettini et al6 Brazil Multiple settings 
Any patient tested for pertussis during study 
period Retrospective    俸   222 Children 161 (72.52) 
Bock et al7 USA Multiple settings Chronic cough (>8 weeks) Retrospective    俸   48 Adults 19 (39.58) 
Bonhoeffer et al8 Switzerland Multiple settings Acute exacerbation of chronic bronchitis Prospective  俸 俸 俸   26 Adults 8 (30.77) 
Cagney et al9 Australia 
Vaccine trial 
cohort Participants of vaccine trial Retrospective    俸   346 Children 5 (1.45) 
Castagnini et al10 USA Secondary care 
Pertussis PCR positive (cases)  
Alternative diagnosis (controls) Case control   俸   66 Children 33 (50.00) 
Cengiz et al11 
Turkey Secondary care 
• Cough >= 7 days 
• Paroxysmal cough 
• Cough + whoop/vomiting/apnoea Prospective 俸 俸 俸   35 Children 26 (5.71) 
Craig et al12 USA Primary care Cough > 2 weeks Prospective  俸 俸 俸 俸 37 Adults 10 (27.03) 
Crowcroft13 UK Secondary care 
Admitted to PICU with respiratory failure, apnoea 
+/- bradycardia or acute life threatening episode Prospective  俸 俸 俸   126 Children 25 (19.84) 
Del Valle-
Mendoza et al14 Peru Secondary care Clinically diagnosed with whooping cough  Prospective  俸 俸   133 Children 51 (38.35) 
Dinu et al15 
Romania Multiple settings 
Cough > 1 week plus one of:  
• Paroxysmal cough 
• Fever 
• Nocturnal cough 
• Apnoea 
• Post-tussive emesis 
• Facial cyanosis Prospective  俸 俸 俸   51 Both 32 (62.75) 
Ferronato et al16 
Brazil Secondary care 
• Dry cough > 2 weeks plus inspiratory 
stridor 
• Paroxysmal cough 
• Vomiting after coughing Retrospective  俸 俸   34 Children 22 (64.71) 
Fine et al17 USA 
Emergency 
department 
Any patient tested for pertussis during study 
period Retrospective  俸   443 Children 38 (8.58) 
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Ghanaie et al 18 Iran Schools Cough >= 2 weeks Prospective  俸 俸   328 Children 21 (6.40) 
Gilberg et al19 France Primary care Cough 7-31 days Prospective  俸 俸 俸   217 Adults 70 (32.26) 
Granstrom et al20 Sweden Secondary care Patients with suspected pertussis Prospective  俸 俸   285 Both 163 (57.19) 
Greenberg et al21 Israel Secondary care 
PICU patients with LRTI as their primary or 
secondary diagnosis on discharge data Retrospective    俸   74 Children 11 (14.86) 
Guinto-Ocampo 
et al22 USA Not reported 
Any patient tested for pertussis during study 
period Retrospective  俸 俸 俸 141 Children 18 (12.77) 
Harnden et al23 UK Primary care Cough >= 2 weeks Prospective    俸   172 Children 64 (37.21) 
Heininger et al24 Germany Primary care Coughing child or household contact  Prospective  俸   3629 Children 601 (16.56) 
Jackson et al25 
USA Primary care 
• Cough >= 5 days 
• Acute respiratory infection judged to 
be more severe than common cold Prospective    俸  319 Adults 47 (14.73) 
Karagul et al26 Turkey Secondary care Cough >= 2 weeks Prospective 俸 俸   214 Adults 15 (7.01) 
Kayina et al27 Uganda Multiple settings Cough >= 2 weeks Prospective    俸 俸   449 Children 67 (14.92) 
Koh et al28 
Malaysia, 
Thailand, 
Taiwan Multiple settings Cough >= 2 weeks Prospective    俸   312 Adults 16 (5.13) 
Mitchell et al29 UK Primary care 
Any patient tested for pertussis during study 
period Retrospective    俸   56 Adults 20 (35.71) 
Miyashita et al30 Japan Secondary care Cough Prospective    俸 俸   1315 Adults 183 (13.92) 
Nicolai et al31 Italy 
Emergency 
department 
Pertussis PCR positive (cases)  
RSV positive and pertussis negative (controls) Case control   俸   38 Children 19 (50.00) 
Nieves et al32 USA Secondary care 
Pertussis PCR positive (cases)  
RSV/flu positive  (controls) Case control 俸 俸 俸 126 Children 32 (25.40) 
Nuolivirta et al33 Finland Secondary care Clinical diagnosis of bronchiolitis Retrospective    俸 俸 142 Children 12 (8.45) 
Park et al 
(2005)34 South Korea Multiple settings Cough 1-12 weeks Prospective  俸 俸   102 Adults 3 (2.94) 
Park et al 
(2014)35 Korea Multiple settings Cough <= 30 days Prospective  俸 俸   490 Adults 34 (6.94) 
Philipson et al36 New Zealand Primary care Cough > 2 weeks Prospective    俸   222 Both 23 (10.36) 
Piedra et al37 USA Secondary care Clinical diagnosis of bronchiolitis Prospective    俸   1405 Children 4 (0.28) 
Raymond et al38 France Secondary care 
• Hospitalised with apnoea +/- cough  
• Paroxysmal or vomiting cough Prospective    俸   41 Children 16 (39.02) 
Rosenthal et al39 USA Primary care Cough > 6 days or suspected pertussis Prospective  俸 俸   38 Adults 10 (26.32) 
Schlapfer et al40 Germany 
Vaccine trial 
cohort Cough >= 1 week Prospective  俸 俸   546 Both 110 (20.15) 
Schmitt-Grohe et 
al41 Germany 
Vaccine trial 
cohort Cough > 2 weeks Prospective  俸 俸 俸   203 Adults 64 (31.53) 
Senzilet et al42 Canada Multiple settings Cough 1-8 weeks Prospective  俸 俸 俸   442 Adults 88 (19.91) 
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Shojaei et al43 Iran Secondary care 
Cough >= 2 weeks with at least one pertussis 
associated symptom Retrospective  俸 俸   118 Children 19 (16.10) 
Siriyakorn et al44 Thailand Secondary care Cough > 2 weeks Prospective   俸 俸   76 Adults 14 (18.42) 
Stefanoff et al45 
Poland Primary care 
Cough >= 2 weeks 
At least one of  
• Paroxysms 
• Inspiratory whooping 
• Post-tussive vomiting without any 
apparent cause Prospective    俸 俸   1232 Both 288 (23.38) 
Steketee et al46 USA 
Setting of 
outbreak Not clear Prospective  俸 俸   255 Adults 107 (41.96) 
Strebel et al 
(1993)47 USA Multiple settings Cough Retrospective  俸   88 Children 33 (37.50) 
Strebel et al 
(2001)48 USA Primary care Cough 7-34 days or acute paroxysmal cough Prospective  俸 俸 俸   212 Adults 27 (12.74) 
Tarr et al49 USA Multiple settings 
Any patient tested for pertussis during study 
period Retrospective    俸   250 Children 24 (9.60) 
Teepe et al50 12 European Countries  Primary care Cough <= 28 days Prospective   俸 俸   3074 Adults 93 (3.03) 
van den Brink et 
al51 Netherlands Secondary care Suspected acute respiratory tract infection Prospective    俸   306 Children 14 (4.58) 
Wirsing von 
König et al52 Germany 
Vaccine trial 
cohort Cough >=1 week Prospective  俸 俸   164 Children 112 (68.29) 
Waters et al53 Canada Multiple settings 
Any patient tested for pertussis during study 
period Case control 俸 俸   485 Children 189 (38.97) 
Wright et al54 USA 
Emergency 
department Cough >= 2 weeks Prospective  俸 俸   75 Adults 16 (21.33) 
Wymann et al55 
Switzerland Primary care 
Cough lasting >=2 weeks with either  
• Epidemiological link to a pertussis 
case  
• At least one pertussis associated 
symptom  
• Clinical judgement Prospective    俸   3721 Children 904 (24.29) 
Yildirim et al56 Turkey Secondary care Cough > 2 weeks Prospective  俸 俸 俸   148 Children 25 (16.89) 
Zouari et al57 Tunisia Multiple settings 
Any patient tested for pertussis during study 
period Prospective  俸 俸 俸   599 Children 120 (20.03) 
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Table 2. Index tests  
Clinical characteristics, examination findings and patient demographics, and number of 
studies in which these were recorded  
 
  
Index test Number of 
studies 
Cough 
characteristic 
Paroxysmal cough 36 
Post-tussive vomiting 36 
Whooping cough 28 
Worse at night 16 
Productive cough 12 
Wheeze 12 
Any cough 7 
Cough duration 6 
Stridor 3 
Other respiratory 
symptoms/findings 
Apnoea 21 
Cyanosis 16 
Rhinorrhoea 10 
Shortness of breath 9 
URTI symptoms 6 
Respiratory distress/hypoxia 5 
Chest crackles 5 
Sore throat 5 
Sneezing 4 
Sinus pain 3 
Hoarseness 2 
Post-tussive gagging 2 
Other clinical 
features 
Fever 28 
Headache 5 
Chest pain 5 
Feeding difficulties 4 
Lymphocytosis 4 
Facial discolouration 3 
Myalgia 3 
Conjunctival changes 3 
White blood cell count 3 
Fatigue 2 
Sweating 2 
Seizure 2 
Post-tussive syncope 2 
Clinical judgement Meets CDC/WHO clinical definition 8 
Clinical suspicion 2 
Patient 
demographics 
Vaccinated 19 
Exposure to contact 16 
Co-morbidity 6 
Smoking 5 
Previous whooping cough 4 
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Table 3.  Meta-analysis 
Pooled estimates of sensitivity and specificity 
 
 
Clinical feature on 
which meta- analysis 
performed  
Age 
category 
Number 
of 
studies  
Sensitivity % 
(95% CI)  
Specificity % 
(95% CI)  
Positive 
likelihood ratio 
(95% CI)  
Negative 
likelihood ratio 
(95% CI)  
Paroxysmal cough Adults 7 93.2 (83.2-97.4) 20.6 (14.7-28.1) 1.17 (1.10-1.25) 0.33 (0.15-0.71) 
Post-tussive vomiting Adults 8 32.5 (24.5-41.6) 77.7 (73.1-81.7) 1.45 (1.19-1.79) 0.87 (0.79-0.96) 
Inspiratory whoop Adults 7 29.8 (18.0-45.2) 79.5 (69.4-86.9) 1.46 (1.07-1.97) 0.88 (0.77-1.00) 
Absence of fever Adults 5 81.8 (72.2-88.7) 18.8 (8.1-37.9) 1.01 (0.86-1.18) 0.97 (0.49-1.90) 
 
Post-tussive vomiting Children 6 60.0 (40.3-77.0) 66.0 (52.5-77.3) 1.76 (1.26-2.48) 0.61 (0.40-0.91) 
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Paroxysmal cough (adults)
Post-tussive vomiting (adults) Whooping cough (adults)
Post-tussive vomiting (children)
Figure 3.
Absence of fever (adults)
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Abbreviations list 
 
CDC  Center for Disease Control  
DFA direct fluorescent antibody test 
PCR  polymerase chain reaction  
PHE  Public Health England  
ROC Receiver Operating Characteristic 
WHO  World Health Organization  
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!
! Online supplements are not copyedited prior to posting and the author(s) take full responsibility for the accuracy of all data.  
!
e-Table 1 
 
 
  ! !
! ! !
! ! !
! ! !
 Study Country (ies) Setting Inclusion criteria Study type 
Pertussis 
outbreak 
Dates of 
recruitment 
Laboratory test 
Total number 
of 
participants 
Age range 
Age 
category 
 
Number (%) 
laboratory 
confirmed 
pertussis 
Culture Serology PCR DFA 
% Male 
Abu Raya et al
5
 
Israel Secondary care <= 4 days of clinically diagnosed acute bronchiolitis Case control 
Not 
recorded 2005-2006 !!   ✖! !! 120 0-52 weeks Children 64.17% 23 (19.17) 
Bellettini et al
6
 
Brazil Multiple settings Any patient tested for pertussis during study period Retrospective  
Not 
recorded 2011-2013 !!
!
✖! !! 222 Not recorded Children 
Not 
recorded 161 (72.52) 
Bock et al
7
 
USA Multiple settings Chronic cough (>8 weeks) Retrospective  No 2007-2011 !! ✖!
!
!! 48 20-88 years Adults 35.42% 19 (39.58) 
Bonhoeffer et al
8
 
Switzerland Multiple settings Acute exacerbation of chronic bronchitis Prospective  
Not 
recorded 2000-2002 ✖! ✖! ✖! !! 26 34-86 years Adults 
Not 
recorded 8 (30.77) 
Cagney et al
9
 
Australia Vaccine trial cohort Participants of vaccine trial Retrospective  Yes 1999-2000 !! ✖!
!
!! 346 Not recorded Children 67.98% 5 (1.45) 
Castagnini et al
10
 
USA Secondary care 
Pertussis PCR positive (cases)  
Alternative diagnosis (controls) Case control 
Not 
recorded 2000-2007 !!
!
✖! !! 66 12-30 days Children 48.48% 33 (50.00) 
Cengiz et al
11
 
Turkey Secondary care 
¥ Cough >= 7 days 
¥ Paroxysmal cough 
¥ Cough + whoop/vomiting/apnoea Prospective 
Not 
recorded 2005-2006 ✖! ✖! ✖! !! 35 
2 months - 13 
years Children 65.71% 26 (5.71) 
Craig et al
12
 
USA Primary care Cough > 2 weeks Prospective  Yes Not recorded ✖! ✖! ✖! ✖! 37 18-22 years Adults 43.24% 10 (27.03) 
Crowcroft
13
 
UK Secondary care 
Admitted to PICU with respiratory failure, apnoea +/- 
bradycardia or acute life threatening episode Prospective  No 1998-1999 ✖! ✖! ✖! !! 126 Not recorded Children 
Not 
recorded 25 (19.84) 
Del Valle-
Mendoza et al
14
 Peru Secondary care Clinically diagnosed with whooping cough  Prospective  No 2010-2013 ✖!
!
✖! !! 133 
<3months - 5 
years Children 54.14% 51 (38.35) 
Dinu et al
15
 
Romania Multiple settings 
Cough > 1 week plus one of:  
¥ Paroxysmal cough 
¥ Fever 
¥ Nocturnal cough 
¥ Apnoea 
¥ Post-tussive emesis 
¥ Facial cyanosis Prospective  
Not 
recorded 2012-2013 ✖! ✖! ✖! !! 51 
3 months - 75 
years Both 43.14% 32 (62.75) 
Ferronato et al
16
 
Brazil Secondary care 
¥ Dry cough > 2 weeks plus inspiratory 
stridor 
¥ Paroxysmal cough 
¥ Vomiting after coughing Retrospective  
Not 
recorded 2009-2012 ✖!
!
✖! !! 34 Not recorded Children 41.18% 22 (64.71) 
Fine et al
17
 
USA Emergency department Any patient tested for pertussis during study period Retrospective  
Not 
recorded 2003-2007 ✖!
! !
!! 443 Not recorded Children 53.05% 38 (8.58) 
Ghanaie et al 
18
 
Iran Schools Cough >= 2 weeks Prospective  
Not 
recorded 2007-2008 ✖!
!
✖! !! 328 6-14 years Children 54.88% 21 (6.40) 
Gilberg et al
19
 
France Primary care Cough 7-31 days Prospective  
Not 
recorded 1999 ✖! ✖! ✖! !! 217 18-88 years Adults 27.19% 70 (32.26) 
Granstrom et al
20
 
Sweden Secondary care Patients with suspected pertussis Prospective  
Not 
recorded 1986-1987 ✖! ✖!
!
!! 285 
0.2-63.2 
years Both 50.53% 163 (57.19) 
Greenberg et al
21
 
Israel Secondary care 
PICU patients with LRTI as their primary or secondary 
diagnosis on discharge data Retrospective  
Not 
recorded 1998-2001 !!
!
✖! !! 74 Not recorded Children 63.51% 11 (14.86) 
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Guinto-Ocampo 
et al
22
 USA Not reported Any patient tested for pertussis during study period Retrospective  
Not 
recorded 2001-2005 ✖!
!
✖! ✖! 141 7-286 days Children 62.41% 18 (12.77) 
Harnden et al
23
 
UK Primary care Cough >= 2 weeks Prospective  
Not 
recorded 2001-2005 !! ✖!
!
!! 172 5-16.9 years Children 54.65% 64 (37.21) 
Heininger et al
24
 
Germany Primary care Coughing child or household contact  Prospective  
Not 
recorded 1991-1992 ✖!
! !
!! 3629 Not recorded Children 
Not 
recorded 601 (16.56) 
Jackson et al
25
 
USA Primary care 
¥ Cough >= 5 days 
¥ Acute respiratory infection judged to be 
more severe than common cold Prospective  
Not 
recorded Not recorded !! ✖!
!
  319 Not recorded Adults 43.89% 47 (14.73) 
Karagul et al
26
 
Turkey Secondary care Cough >= 2 weeks Prospective 
Not 
recorded 2010-2011 ✖!
!
✖! !! 214 10- 39 years Adults 44.86% 15 (7.01) 
Kayina et al
27
 
Uganda Multiple settings Cough >= 2 weeks Prospective  
Not 
recorded 2013 !! ✖! ✖! !! 449 
3 months - 12 
years Children 51.00% 67 (14.92) 
Koh et al
28
 
Malaysia, 
Thailand, 
Taiwan Multiple settings Cough >= 2 weeks Prospective  
Not 
recorded 2012-2013 !! ✖!
!
!! 312 19-83 years Adults 32.69% 16 (5.13) 
Mitchell et al
29
 
UK Primary care Any patient tested for pertussis during study period Retrospective  No 1995-1996 !! ✖!
!
!! 56 16-60 years Adults 
Not 
recorded 20 (35.71) 
Miyashita et al
30
 
Japan Secondary care Cough Prospective  No 2005-2012 !! ✖! ✖! !! 1315 16-79 years Adults 43.65% 183 (13.92) 
Nicolai et al
31
 
Italy Emergency department 
Pertussis PCR positive (cases)  
RSV positive and pertussis negative (controls) Case control 
Not 
recorded 2008-2010 !!
!
✖! !! 38 20-187 days Children 31.58% 19 (50.00) 
Nieves et al
32
 
USA Secondary care 
Pertussis PCR positive (cases)  
RSV/flu positive  (controls) Case control 
Not 
recorded 2009-2010 ✖!
!
✖! ✖! 126 < 3 months Children 
Not 
recorded 32 (25.40) 
Nuolivirta et al
33
 
Finland Secondary care Clinical diagnosis of bronchiolitis Retrospective  
Not 
recorded 2001-2004 !!
!
✖! ✖! 142 
<4 weeks - 6 
months Children 50.00% 12 (8.45) 
Park et al 
(2005)
34
 South Korea Multiple settings Cough 1-12 weeks Prospective  
Not 
recorded 2002-2003 ✖!
!
✖! !! 102 19-83 years Adults 52.94% 3 (2.94) 
Park et al 
(2014)
35
 Korea Multiple settings Cough <= 30 days Prospective  No 2011-2012 ✖!
!
✖! !! 490 Not recorded Adults 27.35% 34 (6.94) 
Philipson et al
36
 
New Zealand Primary care Cough > 2 weeks Prospective  
Not 
recorded 2011 !! ✖!
!
!! 222 5 - 49 years Both 36.73% 23 (10.36) 
Piedra et al
37
 
USA Secondary care Clinical diagnosis of bronchiolitis Prospective  No 2007-2010 !!
!
✖! !! 1405 < 6 months Children 58.29% 4 (0.28) 
Raymond et al
38
 
France Secondary care 
¥ Hospitalised with apnoea +/- cough  
¥ Paroxysmal or vomiting cough Prospective  Yes 2004-2005 !!
!
✖! !! 41 < 4 months Children 
Not 
recorded 16 (39.02) 
Rosenthal et al
39
 
USA Primary care Cough > 6 days or suspected pertussis Prospective  Yes 1993-1994 ✖! ✖!
!
!! 38 13-81 years Adults 
Not 
recorded 10 (26.32) 
Schlapfer et al
40
 
Germany Vaccine trial cohort Cough >= 1 week Prospective  
Not 
recorded 1993-1994 ✖!
!
✖! !! 546 Not recorded Both 
Not 
recorded 110 (20.15) 
Schmitt-Grohe et 
al
41
 Germany Vaccine trial cohort Cough > 2 weeks Prospective  
Not 
recorded 1991-1994 ✖! ✖! ✖! !! 203 18-79 years Adults 31.53% 64 (31.53) 
Senzilet et al
42
 
Canada Multiple settings Cough 1-8 weeks Prospective  
Not 
recorded 1996-1997 ✖! ✖! ✖! !! 442 
12.3-88.4 
years Adults 30.54% 88 (19.91) 
Shojaei et al
43
 
Iran Secondary care 
Cough >= 2 weeks with at least one pertussis associated 
symptom Retrospective  Yes 2008-2012 ✖!
!
✖! !! 118 Not recorded Children 49.15% 19 (16.10) 
Siriyakorn et al
44
 
Thailand Secondary care Cough > 2 weeks Prospective 
Not 
recorded 2010-2011 !! ✖! ✖! !! 76 15-87 years Adults 36.84% 14 (18.42) 
Stefanoff et al
45
 
Poland Primary care 
Cough >= 2 weeks 
At least one of  
¥ Paroxysms 
¥ Inspiratory whooping 
¥ Post-tussive vomiting without any 
apparent cause Prospective  
Not 
recorded 2009-2011 !! ✖! ✖! !! 1232 Not recorded Both 37.42% 288 (23.38) 
Steketee et al
46
 
USA Setting of outbreak Not clear Prospective  Yes 1984 -? ✖! ✖!
!
!! 255 Not recorded Adults 
Not 
recorded 107 (41.96) 
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Strebel et al 
(1993)
47
 USA Multiple settings Cough Retrospective  Yes 1989 ✖!
! !
!! 88 Not recorded Children 
Not 
recorded 33 (37.50) 
Strebel et al 
(2001)
48
 USA Primary care Cough 7-34 days or acute paroxysmal cough Prospective  
Not 
recorded 1995-1996 ✖! ✖! ✖! !! 212 10-49 years Adults 33.96% 27 (12.74) 
Tarr et al
49
 
USA Multiple settings Any patient tested for pertussis during study period Retrospective  Yes 2010 !!
!
✖! !! 250 Not recorded Children 47.60% 24 (9.60) 
Teepe et al
50
 12 European 
Countries  Primary care Cough <= 28 days Prospective No 2007-2010 !! ✖! ✖! !! 3074 NR Adults 40.11% 93 (3.03) 
van den Brink et 
al
51
 Netherlands Secondary care Suspected acute respiratory tract infection Prospective  
Not 
recorded 2007-2009 !!
!
✖! !! 306 
0.1-89.4 
months Children 
Not 
recorded 14 (4.58) 
Wirsing von 
Knig et al
52
 Germany Vaccine trial cohort Cough >=1 week Prospective  
Not 
recorded Not recorded ✖! ✖!
!
!! 164 0-18 Children 
Not 
recorded 112 (68.29) 
Waters et al
53
 
Canada Multiple settings Any patient tested for pertussis during study period Case control Yes 2005-2006 ✖!
!
✖! !! 485 
5 months - 
14.9 years Children 52.58% 189 (38.97) 
Wright et al
54
 
USA Emergency department Cough >= 2 weeks Prospective  No 1992-1994 ✖! ✖!
!
!! 75 NR Adults 34.67% 16 (21.33) 
Wymann et al
55
 
Switzerland Primary care 
Cough lasting >=2 weeks with either  
¥ Epidemiological link to a pertussis case  
¥ At least one pertussis associated symptom  
¥ Clinical judgement Prospective  Yes 1991-2006 !!
!
✖! !! 3721 NR Children 
Not 
recorded 904 (24.29) 
Yildirim et al
56
 
Turkey Secondary care Cough > 2 weeks Prospective  No 2005-2006 ✖! ✖! ✖! !! 148 <1-16 Children 56.76% 25 (16.89) 
Zouari et al
57
 Tunisia Multiple settings Any patient tested for pertussis during study period Prospective  
Not 
recorded 2007-2011 ✖! ✖! ✖! !! 599 
1 day-
11months Children 55.43% 120 (20.03) 
!
!
!
!
!
!
!
!
!
!
!
!
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e-Appendix 1. Search strategy for CINAHL 
 
CINAHL 
# Query Result 
1 (MH "Whooping Cough") 1,067 
2 (MH "Bordetella Pertussis") 81 
3 TI ( whooping cough or pertussis ) AND AB ( whooping cough or pertussis ) 311 
4 1 OR 2 OR 3 1,158 
5 (MH "Cough") 2,455 
6 (MH "Symptoms") 3,974 
7 (MH "Respiratory Sounds") 1,249 
8 TI ( (cough* N5 (onset or time or duration or lasting or onset or hour? or day? or week? or length or long* or 
prolong* or persisten*)) ) OR AB ( (cough* N5 (onset or time or duration or lasting or onset or hour? or day? or 
week? or length or long* or prolong* or persisten*)) ) 
521 
9 TI ( (cough* N5 (rapid* or fast or speed or spell? or bout? or period? or frequen* or sound?)) ) OR AB ( (cough* 
N5 (rapid* or fast or speed or spell? or bout? or period? or frequen* or sound?)) ) 
231 
10 TI ( (cough* N5 (character* or feature? or presentation? or descri* or document*)) ) OR AB ( (cough* N5 
(character* or feature? or presentation? or descri* or document*)) ) 
138 
11 TI ( (cough* N5 (sever* or intens* or type?)) ) OR AB ( (cough* N5 (sever* or intens* or type?)) ) 162 
12 TI ( (cough N5 (productive or nonproductive or dry or explosive or reflex* or refractory or chronic* or vomit*)) ) 
OR AB ( (cough N5 (productive or nonproductive or dry or explosive or reflex* or refractory or chronic* or 
vomit*)) ) 
917 
13 TI paroxysm* OR AB paroxysm* 2,208 
14 TI whoop? OR AB whoop? 17 
15 TI wheez* OR AB wheez* 1,521 
16 TI gasp* OR AB gasp* 112 
17 TI ( ((chest or respirat*) N2 sound*) ) OR AB ( ((chest or respirat*) N2 sound*) ) OR TI (stridor?) OR AB 
(stridor?) 
48 
18 TI ( (posttussive or post-tussive or tussive) ) OR AB ( (posttussive or post-tussive or tussive) ) OR TI (sputum) 
OR AB (sputum) 
1,631 
19 TI ( (clinical exam* or physical exam* or chart review) ) OR AB ( (clinical exam* or physical exam* or chart 
review) ) 
24,236 
20 TI ( (clinical N5 (sign? or symptom? or feature? or presentation or characteristic?)) ) OR AB ( (clinical N5 (sign? 
or symptom? or feature? or presentation or characteristic?)) ) 
22,820 
21 TI ( (physical N5 (sign? or symptom? or feature? or presentation or characteristic?)) ) OR AB ( (physical N5 
(sign? or symptom? or feature? or presentation or characteristic?)) ) 
5,540 
22 TI ( (present* N5 (sign? or symptom? or feature? or characteristic?)) ) OR AB ( (present* N5 (sign? or 
symptom? or feature? or characteristic?)) ) 
7,447 
23 TI ( (symptom* N5 (time or duration or lasting or onset or hour? or day? or week? or length or long* or prolong* 
or persisten* or presentation)) ) OR AB ( (symptom* N5 (time or duration or lasting or onset or hour? or day? or 
week? or length or long* or prolong* or persisten* or presentation)) ) 
11,889 
24 TI (sign? or symptom? or feature? or presentation or characteristic?) 38,216 
25 TI ( ((household* OR house-hold*) N5 contact*) ) OR AB ( ((household* OR house-hold*) N5 contact*) ) 252 
26 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14 OR 15 OR 16 OR 17 OR 18 OR 19 OR 20 OR 21 
OR 22 OR 23 OR 24 OR 25 
104,390 
27 4 AND 26 150 
!
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Clinical 
characteristic
Described as Forest plot SROC plot
Paroxysmal 
cough Paroxysmal cough
Coughing paroxysms
Paroxysms
Coughing spells
Spasmodic cough
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Described as Forest plot SROC plot
Post-tussive
vomiting
Post-tussive vomiting
Post-tussive emesis
Cough with vomiting
Accompanied by 
vomiting
Vomit (s) (ing)
Whooping 
cough
Whooping cough
Whoop
Presence of whoops
Cough with whooping
Inspiratory whoop
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Worse at night Worse at night
Nocturnal cough
Night cough
Mainly at night
Disturbed sleep
Awakened by cough
Productive 
cough
Productive cough
Sputum (production)
Coughing up phlegm
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Wheeze Wheeze (ing)
Wheezing on
auscultation
Wheezing inspiration
Any cough Cough
Increased cough
Persistent cough
Coughing without spells
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Cough 
duration
Cough > 2 weeks
Stridor Stridor
Cough with stridor
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Clinical 
characteristic Described as Forest plot SROC plot
Apnoea Apnoea
Cough with apnoea
Stopped breathing
Apparent life 
threatening event
Apnoea for 30 seconds 
after cough
Cyanosis Cyanosis
Cyanotic spell
Cough with cyanosis
Facial cyanosis
Turned blue/purple
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Clinical 
characteristic Described as Forest plot SROC plot
Rhinorrhoea Rhinorrhoea
Congestion
Coryza
Rhinitis
Shortness of 
breath
Shortness of breath
Dyspnoea
Breathlessness/chest 
pain
SOB
Difficulty breathing
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Clinical 
characteristic Described as Forest plot SROC plot
URTI 
symptoms
URTI symptoms
URI symptoms only (no 
cough)
Influenza-like symptoms
>1 cold-like symptoms: 
water or red eyes, runny 
nose, fever, sore throat, 
vomiting and/or 
diarrhoea
Respiratory 
distress
/hypoxia 
Respiratory distress
Tachypnoea
Fast breathing
Respiratory rate >= 70
Oxygen saturations <
= 94% 
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Clinical 
characteristic Described as Forest plot SROC plot
Chest crackles (Chest) crackle(s)
Crackles on 
auscultation
Chest sounds (rales)
Rales
Sore throat Sore throat
Pharyngitis
 
e-Appendix 2.
 
CHEST Online Supplements are not copyedited prior to posting and the author(s) take full responsibility for the accuracy of all data. 
 
170495
M
A
N
U
S
C
R
IP
T
 
A
C
C
E
P
T
E
D
ACCEPTED MANUSCRIPT
Clinical 
characteristic Described as Forest plot SROC plot
Sneezing Sneezing
Sneezes
Sneezing attack
Sinus pain Sinus pain
Sinus tenderness to 
percussion
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Clinical 
characteristic Described as Forest plot SROC plot
Hoarseness Hoarseness
Post-tussive
gagging
Post-tussive gagging
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OTHER CLINICAL FEATURES
Clinical 
characteristic Described as Forest plot SROC plot
Fever Fever
Fever with cutoff 
(37/37.2/38 C, 100.4 F 
variously)
Temperature elevation
History of fever
Fever since onset of 
cough
Headache Headache(s)
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Clinical 
characteristic Described as Forest plot SROC plot
Chest pain Chest pain
Chest/rib pain
Pleuritic pain
Breathlessness/chest 
pain
Feeding 
difficulties
Feeding difficulties 
before admission
Breast feeding problems
Inadequate oral intake
Aphagia
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Clinical 
characteristic Described as Forest plot SROC plot
Lymphocytosis Lymphocytes > =50%
Lymphocytes >= 
11,000 cell/ml
Lymphocytosis > 
10000/mm3
Lymphocytosis 
(>=10000/ul)
Facial 
discolouration
Facial discolouration
Plethora
Redness
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Clinical 
characteristic Described as Forest plot SROC plot
Myalgia Myalgia
Other muscle pain
Conjunctival 
changes
Conjunctival 
haemorrhage
Conjunctival injection
Conjunctivitis
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Clinical 
characteristic Described as Forest plot SROC plot
White blood 
cell count
WCC > 10000 cells/ml
Leukocytosis 
(>=15000/uL
WBC >= 16,000 cell/ml
Fatigue Malaise
Tiredness
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Clinical 
characteristic Described as Forest plot SROC plot
Sweating Sweating
Seizure History of seizure
Convulsions
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Clinical 
characteristic Described as Forest plot SROC plot
Post-tussive
syncope
Post-tussive syncope
Dizziness
CLINICAL JUDGEMENT
Meets 
CDC/WHO 
clinical
definition
Clinical diagnosis –
CDC
Clinical diagnosis –
WHO
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Clinical 
characteristic Described as Forest plot SROC plot
Clinical 
suspicion
Physician/clinical 
diagnosis of pertussis
Initial clinical diagnosis
PATIENT DEMOGRAPHICS
Vaccinated At least one vaccination
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Clinical 
characteristic Described as Forest plot SROC plot
Exposure to 
contact
Sick household member
Exposed to persistent 
cough
(Household) exposure 
to pertussis
Cough in family member
Contact with cough
Contact with 
known/suspected 
whooping cough
Known exposure to 
pertussis
Reported contact with 
pertussis
Co-morbidity Major co-morbid 
condition
Comorbidity
Pre-existing medical 
conditiosn
History of COPD
History of asthma
HIV status
Pre-existing chest 
diseases
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Clinical 
characteristic Described as Forest plot SROC plot
Smoking Current smoker
Smoker in household
Previous 
whooping 
cough
Whooping cough history
Previous similar cough
Previous (diagnosis of) 
pertussis
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